VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ERIE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ERIEErie Indemnity Company
$238.71$11.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksERIEFinancials

Erie Indemnity Company (ERIE) Financials

30Y historyFree accessUpdated daily

Revenue growth has exhibited significant volatility ranging from 2.3% to 30.4% over the last ten quarters, as management fees remain sensitive to the Exchange's underwriting performance.

ERIE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue4.33B4.07B3.8B3.27B2.84B2.63B2.54B2.48B2.38B1.69B1.6B1.51B6.12B6.27B5.51B4.67B4.76B4.62B2.71B1.18B1.19B1.2B1.2B1.12B964.93M785.68M763.38M704.13M661.68M622.09M583.19M
Revenue Growth %10.85%7.17%16.1%15.1%7.83%3.84%2.39%3.99%40.81%5.96%6.05%-75.42%-2.34%13.77%17.9%-1.83%2.98%70.69%129.59%-0.95%-0.91%-0.04%7.61%15.82%22.81%2.92%8.42%6.42%6.36%6.67%11.2%
Medical Costs & Claims2.53B3.43B3.12B2.75B2.46B2.32B2.2B2.12B2.04B1.4B1.3B1.07B5.29B4.7B4.61B4.47B3.87B4.5B4.26B930.45M934.2M900.73M884.92M820.48M705.87M600.83M549.67M501.06M470.15M451.4M434.96M
Medical Cost Ratio %58.49%84.25%82.18%84.08%86.75%87.92%86.67%85.58%85.55%82.84%81.62%71.38%86.45%75.01%83.69%95.53%81.25%97.31%157.07%78.86%78.42%74.93%73.58%73.42%73.15%76.47%72%71.16%71.06%72.56%74.58%
Gross Profit784.17M640.8M676.46M520.26M376.21M318.1M338.16M357.34M344.34M290.25M293.52M430.92M830M1.57B899M209M893M124.33M-1.55B249.48M257.03M301.39M317.69M297.05M259.06M184.84M213.71M203.07M191.52M170.69M148.23M
Gross Margin %18.12%15.76%17.82%15.92%13.25%12.08%13.33%14.42%14.45%17.16%18.38%28.62%13.55%24.99%16.31%4.47%18.75%2.69%-57.07%21.14%21.58%25.07%26.42%26.58%26.85%23.53%28%28.84%28.94%27.44%25.42%
Gross Profit Growth %--5.27%30.02%38.29%18.27%-5.93%-5.37%3.77%18.64%-1.11%-31.89%-48.08%-47.03%74.3%330.14%-76.6%618.24%108.04%-719.7%-2.94%-14.72%-5.13%6.95%14.67%40.15%-13.51%5.24%6.03%12.21%15.15%30.79%
Operating Expenses1.06B-78.72M000000000198.37M7M7M0-149M-106M-399.67M-707.01M-59.69M-41.77M-38.06M-8.65M2M3.65M2.74M-4.73M-5.69M-4.83M-4.23M-3.82M
OpEx / Revenue %24.55%-1.94%0%0%0%0%0%0%0%0%0%13.18%0.11%0.11%0%-3.19%-2.23%-8.64%-26.1%-5.06%-3.51%-3.17%-0.72%0.18%0.38%0.35%-0.62%-0.81%-0.73%-0.68%-0.66%
Depreciation & Amortization51.68M76.78M56.53M47.41M46.17M37.21M21.2M16.81M13.37M14.83M15.1M16.46M16M14M11M4M12M9M36.93M31.36M36.05M36.85M37.32M4.29M3.99M2.35M2.75M1.77M2M1.89M1.43M
Combined Ratio %83.04%82.32%82.18%84.08%86.75%87.92%86.67%85.58%85.55%82.84%81.62%84.55%86.56%75.12%83.69%92.34%79.02%88.67%130.97%73.8%74.92%71.76%72.86%73.6%73.53%76.82%71.38%70.35%70.32%71.88%73.93%
Operating Income733.95M719.52M676.46M520.26M376.21M318.1M338.16M357.34M344.34M290.25M293.52M232.54M823M1.56B899M358M999M524M-839M309.17M298.8M339.46M326.35M295.05M255.4M182.1M218.45M208.75M196.36M174.92M152.05M
Operating Margin %16.96%17.69%17.82%15.92%13.25%12.08%13.33%14.42%14.45%17.16%18.38%15.45%13.44%24.88%16.31%7.66%20.98%11.33%-30.97%26.2%25.08%28.24%27.14%26.4%26.47%23.18%28.62%29.65%29.68%28.12%26.07%
Operating Income Growth %-6.37%30.02%38.29%18.27%-5.93%-5.37%3.77%18.64%-1.11%26.22%-71.74%-47.24%73.53%151.12%-64.16%90.65%162.46%-371.37%3.47%-11.98%4.02%10.61%15.53%40.25%-16.64%4.64%6.31%12.26%15.04%10.17%
EBITDA785.63M796.3M732.99M567.67M422.38M355.31M359.35M374.15M357.71M305.08M308.61M249M839M1.57B910M362M1.01B533M-802.07M340.53M334.85M376.31M363.66M299.35M259.39M184.45M221.19M210.52M198.36M176.81M153.48M
EBITDA Margin %18.16%19.58%19.31%17.37%14.87%13.49%14.17%15.1%15.02%18.03%19.33%16.54%13.7%25.1%16.51%7.74%21.23%11.53%-29.61%28.86%28.11%31.3%30.24%26.79%26.88%23.48%28.98%29.9%29.98%28.42%26.32%
Interest Expense00002.01M4.13M731K856K2.46M1.24M101K00000000000000000000
Non-Operating Income69.76M8.92M-33.35M-32.56M-6.03M4.08M1.64M-1.67M002.41M0-7M-7M0000000115.24M066.74M00-5.49M0000
Pretax Income726.18M710.6M757.28M561.94M376.45M376.4M368.51M396.7M371.32M315.69M320.09M266.25M251.26M246.61M899M358M999M524M-839M309.17M298.8M339.46M326.35M295.05M255.4M182.1M218.45M208.75M196.36M174.92M152.05M
Pretax Margin %16.78%17.47%19.95%17.19%13.25%14.29%14.53%16.01%15.59%18.66%20.05%17.68%4.1%3.93%16.31%7.66%20.98%11.33%-30.97%26.2%25.08%28.24%27.14%26.4%26.47%23.18%28.62%29.65%29.68%28.12%26.07%
Income Tax154.79M151.27M156.97M115.88M77.88M78.54M75.21M79.88M83.1M118.7M109.72M91.57M83.76M84M280M90M339M78M-223M99.14M99.06M111.73M105.14M102.24M84.89M60.56M71.16M65.65M61.81M56.34M46.92M
Effective Tax Rate %21.32%21.29%20.73%20.62%20.69%20.87%20.41%20.14%22.38%37.6%34.28%34.39%33.34%34.06%31.15%25.14%33.93%14.89%26.58%32.07%33.15%32.92%32.22%34.65%33.24%33.26%32.58%31.45%31.48%32.21%30.86%
Net Income571.39M559.34M600.31M446.06M298.57M297.86M293.3M316.82M288.22M197M210.37M174.68M167.5M162.61M160M169M162M108M69M212.94M204.03M231.1M226.41M199.72M172.13M122.26M152.39M143.11M134.55M118.58M105.13M
Net Margin %13.2%13.75%15.82%13.65%10.51%11.31%11.56%12.79%12.1%11.64%13.18%11.6%2.74%2.59%2.9%3.61%3.4%2.34%2.55%18.05%17.13%19.22%18.83%17.87%17.84%15.56%19.96%20.32%20.33%19.06%18.03%
Net Income Growth %-6.97%-6.83%34.58%49.4%0.24%1.55%-7.42%9.92%46.31%-6.35%20.43%4.28%3.01%1.63%-5.33%4.32%50%56.52%-67.6%4.37%-11.72%2.07%13.36%16.03%40.79%-19.77%6.49%6.36%13.47%12.79%12.38%
EPS (Diluted)10.8410.6211.488.535.715.695.616.064.933.764.013.333.183.082.993.082.851.891.193.433.133.343.212.812.411.712.121.951.811.591.41
EPS Growth %-7.49%-7.49%34.58%49.39%0.35%1.43%-7.43%22.92%31.12%-6.23%20.42%4.72%3.25%3.01%-2.92%8.07%50.79%58.82%-65.31%9.58%-6.29%4.05%14.23%16.6%40.94%-19.34%8.72%7.73%13.84%12.77%11.9%
EPS (Basic)-12.0112.899.586.416.406.306.804.934.234.523.753.593.463.383.453.182.101.343.803.453.693.543.092.681.712.121.951.811.591.41
Diluted Shares Outstanding52.69M52.69M52.69M52.68M46.19M46.19M52.69M58.42M52.7M58.44M58.54M58.6M58.72M58.96M59.65M61.17M63M63.55M64.09M68.25M65.26M69.29M77.4M71.09M71.16M71.34M71.95M73.58M74.57M74.58M74.56M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Exchange Surplus Sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Amidst Structural Constraints

According to recent financial disclosures, ERIE's revenue growth has exhibited significant volatility, ranging from 2.3% to 30.4% over the last ten quarters, reflecting the inherent sensitivity of management fees to the underlying premium volume generated by the Erie Insurance Exchange's regional policyholder base.

The wide variance in quarterly revenue growth suggests that ERIE's top-line performance is heavily dependent on the Exchange's ability to successfully execute rate increases in a competitive Mid-Atlantic market. Investors should monitor whether the recent deceleration to 2.3% in 2026Q1 indicates a cooling in new policy acquisition or a strategic shift in the Exchange's underwriting appetite.

Underwriting Volatility Impacts Fee Stability

As reported in quarterly filings, the combined ratio for the Exchange has fluctuated significantly, with a notable spike to 85.4% in 2025Q4, which directly influences the operational environment for ERIE's fee-based management model and complicates the predictability of long-term margin expansion.

While ERIE does not bear underwriting risk directly, the correlation between the Exchange's loss ratios and ERIE's operating income suggests that sustained underwriting pressure may eventually force a recalibration of management fee rates. The lack of consistent combined ratio data across all periods warrants caution when assessing the long-term sustainability of current operating margins.

Structural Risks of Reciprocal Model

Based on an analysis of the company's unique attorney-in-fact structure, ERIE's earnings appear vulnerable to the Exchange's surplus health, as evidenced by the sharp 58.8% decline in net income during 2025Q4 when loss ratios reached 85.4% and impacted the broader financial ecosystem.

The reliance on the Exchange's surplus to absorb catastrophe losses creates a potential ceiling on ERIE's fee extraction capabilities during periods of high claim severity. Analysts should consider that ERIE's profitability is essentially a derivative of the Exchange's underwriting discipline, making it susceptible to regional weather-related volatility that the company cannot directly control.

Operating Efficiency and Agency Costs

Financial statements indicate that ERIE maintains a disciplined fixed-cost base, yet the significant outflow of agent commissions remains a primary variable expense that effectively caps the company's gross margin potential at approximately 15.76% under current operating conditions.

The company's reliance on an independent agency force provides a durable distribution moat but necessitates a high level of ongoing compensation expense that limits operating leverage. Future margin improvement appears contingent on the company's ability to drive technological efficiencies that reduce the administrative burden of policy issuance without alienating its core agency partners.

ERIE — Frequently Asked Questions

Quick answers to the most common questions about buying ERIE stock.

What was Erie Indemnity Company's (ERIE) revenue in 2025?

For fiscal year 2025, Erie Indemnity Company (ERIE) reported total revenue of $4.07B. This represents a 597.4% increase compared to $583.2M in 1996.

Is Erie Indemnity Company (ERIE) profitable?

Erie Indemnity Company (ERIE) is profitable, generating $559.3M in net income for the fiscal year ending 2025 with a net profit margin of 13.8%.

What is Erie Indemnity Company's operating profit margin?

Erie Indemnity Company (ERIE) reported an operating income of $719.5M, resulting in an operating profit margin of 17.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Erie Indemnity Company's gross profit and gross margin?

Erie Indemnity Company (ERIE) generated $640.8M in gross profit for the year, representing a gross profit margin of 15.8%. This demonstrates the company's core pricing power and production efficiency.